• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与 83884 例中国患者降压药物依从性相关的因素:一项队列研究。

Factors associated with antihypertensive drug compliance in 83,884 Chinese patients: a cohort study.

机构信息

School of Public Health, Prince of Wales Hospital, 4/F, Shatin, NT, Hong Kong, China.

出版信息

J Epidemiol Community Health. 2010 Oct;64(10):895-901. doi: 10.1136/jech.2009.091603. Epub 2010 Aug 6.

DOI:10.1136/jech.2009.091603
PMID:20693495
Abstract

BACKGROUND

Few studies address the profiles of antihypertensive compliance among ethnic Chinese. The levels of and factors associated with antihypertensive drug compliance among Chinese patients were evaluated in this study.

METHODS

All Chinese hypertensive patients who paid at least two consecutive visits in any government primary care clinics for antihypertensive drug refill in a large territory of Hong Kong from January 2004 to June 2007 were included. Medication possession ratio (MPR), defined as the ratio of total days of medication supplied (not including the last prescription) to total days in a period of time, was used a measure of drug compliance.

RESULTS

From 83,884 eligible patients, 71,685 (85.5%) had good compliance to antihypertensive drugs (MPR>or=80%). Binary logistic regression analysis was conducted, with good compliance as the outcome variable while controlling for potential confounders. Advanced age (adjusted ORs (aOR) 1.36-1.55, p<0.001), female gender (aOR for male patients 0.84, 95% CI 0.80 to 0.87, p<0.001), payment of fees (aOR 1.14, 95% CI 1.09 to 1.19, p<0.001), attendance in family medicine specialist clinic (aOR 1.52, 95% CI 1.40 to 1.66, p<0.001), follow-up visits (aOR 3.21, 95% CI 3.06 to 3.36, p<0.001) and use of drugs acting on the renin-angiotensin system (aOR 1.18, 95% CI 1.07 to 1.30, p=0.001) were positively associated with good compliance to drugs. Use of β-blockers was negatively associated with drug compliance (aOR 0.78, 95% CI 0.73 to 0.84, p<0.001).

CONCLUSIONS

Physicians should practice caution when prescribing antihypertensive drugs to patients with these factors where closer monitoring of their compliance patterns is warranted.

摘要

背景

很少有研究涉及华裔人群的降压药物依从性特征。本研究评估了中国患者降压药物依从性的水平和相关因素。

方法

纳入 2004 年 1 月至 2007 年 6 月期间在香港某大片地区的政府初级保健诊所因降压药物续配而至少连续就诊两次的所有华裔高血压患者。药物使用比例(MPR)定义为总用药天数(不包括最后一次处方)与一段时间内总天数的比值,作为药物依从性的衡量标准。

结果

在 83884 名合格患者中,71685 名(85.5%)患者对降压药物有良好的依从性(MPR≥80%)。将良好的依从性作为因变量,在控制潜在混杂因素的情况下进行二项逻辑回归分析。结果显示,高龄(校正后 ORs(aOR)1.36-1.55,p<0.001)、女性(男性患者 aOR 为 0.84,95%CI 0.80-0.87,p<0.001)、付费(aOR 1.14,95%CI 1.09-1.19,p<0.001)、家庭医学专科诊所就诊(aOR 1.52,95%CI 1.40-1.66,p<0.001)、随访(aOR 3.21,95%CI 3.06-3.36,p<0.001)和使用肾素-血管紧张素系统药物(aOR 1.18,95%CI 1.07-1.30,p=0.001)与药物良好依从性呈正相关。使用β受体阻滞剂与药物依从性呈负相关(aOR 0.78,95%CI 0.73-0.84,p<0.001)。

结论

医生在为具有这些因素的患者开具降压药物时应谨慎,并应密切监测其依从性模式。

相似文献

1
Factors associated with antihypertensive drug compliance in 83,884 Chinese patients: a cohort study.与 83884 例中国患者降压药物依从性相关的因素:一项队列研究。
J Epidemiol Community Health. 2010 Oct;64(10):895-901. doi: 10.1136/jech.2009.091603. Epub 2010 Aug 6.
2
Short-term adherence to beta-blocker therapy among ethnic Chinese patients with hypertension: a cohort study.汉族高血压患者短期服用β受体阻滞剂治疗的依从性:一项队列研究。
Clin Ther. 2009 Oct;31(10):2170-7; discussion 2150-1. doi: 10.1016/j.clinthera.2009.10.004.
3
Switching of antihypertensive drugs among 93,286 Chinese patients: a cohort study.93286 例中国患者的降压药物转换:一项队列研究。
J Hum Hypertens. 2010 Oct;24(10):669-77. doi: 10.1038/jhh.2009.109. Epub 2010 Jan 7.
4
Discontinuation of angiotensin-converting enzyme inhibitors: a cohort study.血管紧张素转换酶抑制剂的停药:一项队列研究。
J Clin Pharm Ther. 2012 Jun;37(3):335-41. doi: 10.1111/j.1365-2710.2011.01300.x. Epub 2011 Oct 24.
5
Adherence to lipid-lowering agents among 11,042 patients in clinical practice.临床实践中 11042 例患者对降脂药物的依从性。
Int J Clin Pract. 2011 Jul;65(7):741-8. doi: 10.1111/j.1742-1241.2011.02706.x.
6
Factors associated with compliance to thiazide diuretics among 8551 Chinese patients.与 8551 例中国患者噻嗪类利尿剂依从性相关的因素。
J Clin Pharm Ther. 2011 Apr;36(2):179-86. doi: 10.1111/j.1365-2710.2010.01174.x.
7
First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review.韩国开始使用抗高血压药物的门诊患者的第一年治疗依从性:一项回顾性索赔审查结果
Clin Ther. 2009 Jun;31(6):1309-20. doi: 10.1016/j.clinthera.2009.06.011.
8
Subjects at risk of discontinuation of lipid-lowering agents: a 6-month cohort study among 12,875 patients in a chinese population.降脂药物停药风险人群:中国人群中 12875 例患者的 6 个月队列研究。
Clin Ther. 2011 May;33(5):617-28. doi: 10.1016/j.clinthera.2011.04.019.
9
Factors influencing antihypertensive medication compliance in Taiwan: a nationwide population-based study.影响台湾地区高血压患者药物治疗依从性的因素:一项基于全国人口的研究。
Eur J Prev Cardiol. 2013 Dec;20(6):930-7. doi: 10.1177/2047487312451252. Epub 2012 Jun 11.
10
Duration of initial antihypertensive prescription and medication adherence: a cohort study among 203,259 newly diagnosed hypertensive patients.初始抗高血压处方的持续时间和药物依从性:一项对203,259名新诊断高血压患者的队列研究。
Int J Cardiol. 2015 Mar 1;182:503-8. doi: 10.1016/j.ijcard.2014.12.058. Epub 2014 Dec 23.

引用本文的文献

1
Global Burden, Regional Differences, Trends, and Health Consequences of Medication Nonadherence for Hypertension During 2010 to 2020: A Meta-Analysis Involving 27 Million Patients.2010 年至 2020 年期间全球范围内高血压药物治疗不依从的负担、地区差异、趋势及其对健康的影响:一项涉及 2700 万患者的荟萃分析
J Am Heart Assoc. 2022 Sep 6;11(17):e026582. doi: 10.1161/JAHA.122.026582. Epub 2022 Sep 3.
2
Analysis of Adherence to Antihypertensive Drugs in Chinese Patients with Hypertension: A Retrospective Analysis Using the China Health Insurance Association Database.中国高血压患者抗高血压药物依从性分析:使用中国健康保险协会数据库的回顾性分析
Patient Prefer Adherence. 2020 Jul 17;14:1195-1204. doi: 10.2147/PPA.S243665. eCollection 2020.
3
Sex differences in the adherence of antihypertensive drugs: a systematic review with meta-analyses.抗高血压药物依从性的性别差异:系统评价和荟萃分析。
BMJ Open. 2020 Jul 8;10(7):e036418. doi: 10.1136/bmjopen-2019-036418.
4
The impact of early comprehensive geriatric screening on the readmission rate in an acute geriatric ward: a quasi-experimental study.早期综合老年筛查对急性老年病房再入院率的影响:一项准实验研究。
BMC Geriatr. 2019 Oct 24;19(1):285. doi: 10.1186/s12877-019-1312-y.
5
Effectiveness of low-cost reminder package combined with case-based health education to improve hypertensive patients' medication adherence: a clustered randomized controlled trial.低成本提醒包联合病例式健康教育提高高血压患者用药依从性的效果:一项整群随机对照试验
Patient Prefer Adherence. 2019 Jul 10;13:1083-1092. doi: 10.2147/PPA.S194667. eCollection 2019.
6
Cohort profile: the Lanxi Cohort study on obesity and obesity-related non-communicable diseases in China.队列研究简介:中国兰溪市肥胖及肥胖相关非传染性疾病研究。
BMJ Open. 2019 May 9;9(5):e025257. doi: 10.1136/bmjopen-2018-025257.
7
Self-Reported Medication Adherence Measured With Morisky Medication Adherence Scales and Its Determinants in Hypertensive Patients Aged ≥60 Years: A Systematic Review and Meta-Analysis.使用Morisky药物依从性量表测量的≥60岁高血压患者自我报告的药物依从性及其决定因素:一项系统评价和荟萃分析。
Front Pharmacol. 2019 Mar 1;10:168. doi: 10.3389/fphar.2019.00168. eCollection 2019.
8
Post-discharge evaluation of medication adherence and knowledge of hypertension among hypertensive stroke patients in northwestern China.中国西北部高血压性中风患者出院后药物依从性及高血压知识评估
Patient Prefer Adherence. 2017 Nov 20;11:1915-1922. doi: 10.2147/PPA.S147605. eCollection 2017.
9
Non-adherence to anti-hypertensive medication in low- and middle-income countries: a systematic review and meta-analysis of 92443 subjects.低收入和中等收入国家抗高血压药物治疗的不依从性:对92443名受试者的系统评价和荟萃分析
J Hum Hypertens. 2017 Jan;31(1):14-21. doi: 10.1038/jhh.2016.31. Epub 2016 Jun 16.
10
Sleep duration and treatment compliance: a population-based cross-sectional study of hypertensive patients in Bangladesh.睡眠时间与治疗依从性:一项基于孟加拉国高血压患者群体的横断面研究。
BMC Res Notes. 2016 May 13;9:271. doi: 10.1186/s13104-016-2075-6.